During the past decade, Versiti Wisconsin conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Versiti Wisconsin" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Versiti Wisconsin" are "Sickle Cell Disease" (1 trials) and "Venous Thromboembolism" (1 trials). Many other conditions were trialed in "Versiti Wisconsin" in a lesser frequency.

Most popular intervention types in "Versiti Wisconsin" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "Standard of Care" (1 trials) and "Transfusion" (1 trials). Other intervention names were less common.

The vast majority of trials in "Versiti Wisconsin" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Versiti Wisconsin". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Versiti Wisconsin, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Versiti Wisconsin, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".